AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17434511
Drug: GnRH-a (tryptorelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH-a (tryptorelin or leuprorelin, 3.75 mg every 28 days)
Trial: 17434511
Drug: Continuous estroprogestin
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous estroprogestin (ethynilestradiol, 0.03 mg plus gestoden, 0.75 mg)
Trial: 19665279
Drug: Dietary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary therapy (vitamins, minerals salts, lactic ferments, fish oil)
Trial: 17434511
Drug: Postoperative medical
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative medical and dietary therapy
Trial: 15366275
Drug: Realism framework
RxNorm normalized name: Human monoclonal antibody based on an IgG1 lambda framework against human interferon gamma
DrugBank: EI-001 (DB17596)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Realism framework in evidence based medicine
Trial: 15366275
Drug: Evidence based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence based medicine adopting realism
Trial: 11820707
Drug: Risedronate 5
RxNorm normalized name: risedronate 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 5 mg daily for 3 months
Trial: 22094303
Drug: Individualised patient
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised patient care as an adjunct to standard care
Trial: 17591563
Drug: CHOP chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP chemotherapy (Cyclophosphamide, doxorubicin, vincristine, and prednisone)
Trial: 17591563
Drug: CHOP chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP chemotherapy with rituximab
Trial: 17591563
Drug: Dose-dense and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-dense and/or dose-intense regimens
Trial: 2396473
Drug: Parotin (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parotin (oral adjuvant)
Trial: 2396473
Drug: Taurine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (oral adjuvant)
Trial: 2396473
Drug: Taurine +
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine + Lithium (oral adjuvant)
Trial: 2396473
Drug: Taurine +
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine + Parotin (oral adjuvant)
Trial: 2396473
Drug: Taurine +
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine + Parotin + Lithium (oral adjuvant)
Trial: 2396473
Drug: Taurine +
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine + Lithium + Parotin (oral adjuvants)
Trial: 2396473
Drug: Non-adjuvanted vaccines
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-adjuvanted vaccines (control)
Trial: 314716
Drug: Both analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both analgesics
Trial: 31722374
Drug: Anti-hyperglycemic medications
RxNorm normalized name: pramoxine hydrochloride Medicated Pad [Scalpicin Anti-Itch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-hyperglycemic medications
Trial: 23141816
Drug: Serelaxin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serelaxin (30 μg/kg per day)
Trial: 19217991
Drug: Fixed-dose warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose warfarin 1 mg per day
Trial: 31479105
Drug: Dose-adjusted warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-adjusted warfarin
Trial: 2178534
Drug: No warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No warfarin
Trial: 19217991
Drug: Warfarin (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (combined fixed-dose and dose-adjusted)
Trial: 11194244
Drug: Buffered regular
RxNorm normalized name: INSULIN,REGULAR,HUMAN BUFFERED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered regular human insulin
Trial: 9385624
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of immediate-release PPA (administered orally via a gelatin capsule)
Trial: 7611920
Drug: Carvedilol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (25 mg/day for 8 weeks)
Trial: 7611920
Drug: Nifedipine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (40 mg/day b.i.d. for 8 weeks)
Trial: 28318161
Drug: Periodontal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal therapy and root-canal treatment (experimental group)
Trial: 28318161
Drug: Periodontal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal treatment alone (control group)
Trial: 16450574
Drug: Desloratadine/pseudoephedrine, 2.5/120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine/pseudoephedrine, 2.5/120 mg b.i.d.
Trial: 16450574
Drug: Desloratadine, 5
RxNorm normalized name: Desloratadine, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine, 5 mg once per day
Trial: 16450574
Drug: Pseudoephedrine, 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine, 120 mg b.i.d.
Trial: 12378662
Drug: Ropivacaine 2
RxNorm normalized name: fentanyl-ropivacaine 2 mcg/mL-0.1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2 mg ml‐1
Trial: 12378662
Drug: Ropivacaine 5
RxNorm normalized name: fentanyl-ropivacaine 5 mcg/mL-0.1%-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 5 mg ml‐1
Trial: 12378662
Drug: Ropivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 7.5 mg ml‐1
Trial: 12378662
Drug: Ropivacaine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 10 mg ml‐1
Trial: 9924905
Drug: Vigabatrin (VGB)
DrugBank: Vigabatrin (DB01080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vigabatrin (VGB) 1 g/day
Trial: 9924905
Drug: Vigabatrin (VGB)
DrugBank: Vigabatrin (DB01080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vigabatrin (VGB) 3 g/day
Trial: 9924905
Drug: Vigabatrin (VGB)
DrugBank: Vigabatrin (DB01080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vigabatrin (VGB) 6 g/day
Trial: 8849986
Drug: Isoflurane 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflurane 2% administered before sternotomy for ten minutes
Trial: 8849986
Drug: Isoflurane 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflurane 2% administered after sternotomy for ten minutes
Trial: 28608719
Drug: Home monitoring
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home monitoring intervention with spirometry and symptom monitoring twice per week.
Trial: 24973731
Drug: Functionally orientated
RxNorm normalized name: Papaver orientale seed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functionally orientated treatment (SDA)
Trial: 23827658
Drug: Training, support,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training, support, and activity therapy intervention
Trial: 12921496
Drug: Methylprednisolone sodium
RxNorm normalized name: methylPREDNISolone sodium phosphate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone sodium succinate 50 mg intravenous piggyback (IVPB) prior to infusion and repeated 1 hour into the infusion
Trial: 12921496
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen of acetaminophen 650 mg orally with diphenhydramine 50 mg intravenously
Trial: 9477787
Drug: Root form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Root form implants placed in augmented sinuses
Trial: 3544625
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (KABI 2165) 5,000 U once daily
Trial: 3544625
Drug: Conventional heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional heparin 5,000 IU twice daily
Trial: 30961460
Drug: Omega-3 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 (2 g) plus Vitamin E (400 IU)
Trial: 15923414
Drug: Home Treatment
RxNorm normalized name: Home-brew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home Treatment (HT) with low molecular weight heparin (LMWH) followed by warfarin
Trial: 15923414
Drug: Home Treatment
RxNorm normalized name: Home-brew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home Treatment (HT) with low molecular weight heparin (LMWH) alone
Trial: 15923414
Drug: Hospitalized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospitalized treatment with LMWH and warfarin
Trial: 15923414
Drug: Hospitalized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospitalized treatment with LMWH alone
Trial: 15923414
Drug: Hospitalized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospitalized treatment
Trial: 1882906
Drug: sucralfate, 1
RxNorm normalized name: Sucralfate, 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sucralfate, 1 g q.i.d., 0.5 hour before meals on an empty stomach or at bedtime
Trial: 1882906
Drug: ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine, 150 mg b.i.d.
Trial: 1882906
Drug: sucralfate, 1
RxNorm normalized name: Sucralfate, 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sucralfate, 1 g b.i.d. (before breakfast and at bedtime)
Trial: 1882906
Drug: ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine, 150 mg at bedtime
Trial: 7057465
Drug: Supplemental albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental albumin therapy
Trial: 7057465
Drug: Supplemental steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental steroid therapy
Trial: 24388622
Drug: ezetimibe +
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ezetimibe + fluvastatin (10 mg/day + 30 mg/day)
Trial: 24388622
Drug: fluvastatin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluvastatin alone (30 mg/day)
Trial: 22107110
Drug: Text message
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text message programme targeted at changing illness and medication beliefs over 18 weeks
Trial: 21352639
Drug: Olopatadine hydrochloride
RxNorm normalized name: Olopatadine Hydrochloride
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olopatadine hydrochloride nasal spray 0.6% (OLO)
Trial: 21352639
Drug: Azelastine hydrochloride
RxNorm normalized name: Azelastine Hydrochloride
DrugBank: Azelastine (DB00972)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Azelastine hydrochloride nasal spray 0.1% (AZE)
Trial: 20805112
Drug: Colchicine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (1.0 mg twice daily for the first day followed by 0.5 mg twice daily for 1 month for patients ≥70 kg; halved doses for patients <70 kg or intolerant)
Trial: 15195238
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza virus vaccine (TVV) + Trivalent live cold‐adapted influenza virus vaccine (CAIV-T)
Trial: 15195238
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza virus vaccine (TVV) + Placebo (P)
Trial: 7659479
Drug: HbOC (Haemophilus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HbOC (Haemophilus b oligosaccharide conjugate vaccine) administered simultaneously with DTaP or DTP
Trial: 7659475
Drug: DTaP vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP vaccines
Trial: 7659479
Drug: DTP vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP vaccines
Trial: 23992556
Drug: Broccoli consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli consumption (250 g/day for 10 days)
Trial: 18372433
Drug: Iloprost 50
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost 50 microg twice daily
Trial: 18372433
Drug: Iloprost 100
RxNorm normalized name: ILOPROST 100MCG/ML INJ,SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloprost 100 microg twice daily
Trial: 18372433
Drug: Iloprost 150
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost 150 microg twice daily
Trial: 9443519
Drug: Caffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated coffee (1.5 mg/kg caffeine/body weight)
Trial: 8197032
Drug: Ticarcillin-clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticarcillin-clavulanic acid (T-C) 3.1 g
Trial: 8197032
Drug: Ampicillin-sulbactam (A-S)
RxNorm normalized name: ampicillin / sulbactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin-sulbactam (A-S) 3 g
Trial: 3295035
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 or 50 mg given thrice daily)
Trial: 3295035
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg given thrice daily)
Trial: 17383080
Drug: BCG RIVM
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG RIVM 2 x 10(8) CFU weekly for 6 wk
Trial: 17383080
Drug: MMC 20
RxNorm normalized name: MMC
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMC 20 mg weekly for 6 wk
Trial: 17383080
Drug: MMC 20
RxNorm normalized name: MMC
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMC 20 mg weekly for 6 wk followed by monthly instillations for 3 yr
Trial: 11207651
Drug: Albendazole treatment
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole treatment group
Trial: 11444448
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control Group)
Trial: 29362596
Drug: Cerebrolysin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (30 ml/day for 10 days)
Trial: 26004611
Drug: EMG biofeedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMG biofeedback treatment after BTX-A injection
Trial: 26004611
Drug: Botulinum toxin-A
RxNorm normalized name: Botulinum toxin A
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Botulinum toxin-A (BTX-A) injection
Trial: 21147712
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg iron as ferrous sulfate
Trial: 22094835
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg iron as NaFeEDTA
Trial: 19362994
Drug: Benfluorex (BFL)
RxNorm normalized name: benfluorex
DrugBank: Benfluorex (DB09022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benfluorex (BFL) 3 tablets/day for 24 weeks
Trial: 16314385
Drug: Pro-active call
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pro-active call centre-based stepped treatment support
Trial: 11401971
Drug: MACconj (meningococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MACconj (meningococcal group A+C conjugate vaccine)
Trial: 11401971
Drug: MACPS (meningococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MACPS (meningococcal group A+C polysaccharide vaccine)
Trial: 8988699
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate 10 mg
Trial: 8988699
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate 20 mg
Trial: 3307567
Drug: Chlorpheniramine maleate
RxNorm normalized name: Chlorpheniramine Maleate
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine maleate (CM) 4.0 mg orally, 4 times daily for 4 days
Trial: 3307567
Drug: Diphenhydramine hydrochloride
RxNorm normalized name: Diphenhydramine Hydrochloride
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diphenhydramine hydrochloride (DH) 2 mg intranasally, 4 times daily for 5 days
Trial: 9279176
Drug: Standard parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard parenteral nutrition
Trial: 23649080
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg sublingual piroxicam (two 20‐mg tablets once daily on the first and second postoperative days, followed by one 20‐mg tablet on the third postoperative day)
Trial: 23649080
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg oral diclofenac (50 mg thrice a day on the first, second, and third postoperative days)
Trial: 12114372
Drug: BAYx1005 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAYx1005 (500 mg bid)
Trial: 10206217
Drug: Intravenously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenously administered procainamide hydrochloride
Trial: 7781621
Drug: Stricter guidelines
RxNorm normalized name: Euphrasia stricta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stricter guidelines for diagnosis and treatment of gestational diabetes
Trial: 31212248
Drug: Sertraline (∼1 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (∼1 μg L‐1)
Trial: 31212248
Drug: Methamphetamine (∼1 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methamphetamine (∼1 μg L‐1)
Trial: 27506203
Drug: Reinforcement-Induced Movement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinforcement-Induced Movement Therapy (RIMT) with goal-oriented movement amplification in VR
Trial: 24824360
Drug: Tryptophan intake
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tryptophan intake of 15 mg·kg·day
Trial: 24824360
Drug: Recommended intake
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recommended intake of 29 mg·kg·day
Trial: 20089937
Drug: Topiramate 25
RxNorm normalized name: topiramate 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 25 mg/kg/d
Trial: 20089937
Drug: Topiramate 15
RxNorm normalized name: topiramate 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 15 mg/kg/d
Trial: 20089937
Drug: Topiramate 5
RxNorm normalized name: topiramate 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 5 mg/kg/d
Trial: 18975532
Drug: Sevoflurane with
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane with nitrous oxide (Group G)
Trial: 15983916
Drug: Etanercept (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (a soluble TNF receptor)
Trial: 15983916
Drug: Anti-TNF antibody
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-TNF antibody infliximab
Trial: 1481832
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid (dl-Leucovorin, 15 mg/day)
Trial: 31216086
Drug: Sofosbuvir-velpatasvir (400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir-velpatasvir (400/100 mg) once daily for 12 weeks
Trial: 19056576
Drug: Capsinoids (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsinoids (6 mg/d)
Trial: 15559606
Drug: Both preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both preparations of IFN‐beta 1‐a
Trial: 9716578
Drug: Ticlopidine 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 500 mg/d
Trial: 9716578
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg/d + Ticlopidine 500 mg/d
Trial: 8383688
Drug: Granisetron 40
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 40 micrograms/kg (additional doses allowed)
Trial: 7021163
Drug: Bronchodilator aerosol
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchodilator aerosol with tube extension (terbutaline sulphate 0.25 mg)
Trial: 31029045
Drug: Higher cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher cocoa chocolate (HCC; ∼90%; 20 g daily)
Trial: 31029045
Drug: Lower cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower cocoa chocolate (LCC; ∼55%; 20 g daily)
Trial: 23996803
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg nebivolol per day for 3 months